Defiance Daily Target 2X Long IONQ ETF (NASDAQ:IONX) Sees Strong Trading Volume – Here’s Why

Shares of Defiance Daily Target 2X Long IONQ ETF (NASDAQ:IONXGet Free Report) saw unusually-strong trading volume on Friday . Approximately 1,865,995 shares were traded during trading, a decline of 3% from the previous session’s volume of 1,925,519 shares.The stock last traded at $82.50 and had previously closed at $70.89.

Defiance Daily Target 2X Long IONQ ETF Stock Performance

The stock’s fifty day moving average is $38.42 and its two-hundred day moving average is $58.71.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of IONX. Hollencrest Capital Management purchased a new position in shares of Defiance Daily Target 2X Long IONQ ETF during the fourth quarter worth about $48,000. Flow Traders U.S. LLC purchased a new position in shares of Defiance Daily Target 2X Long IONQ ETF during the second quarter worth about $270,000. Jump Financial LLC purchased a new position in shares of Defiance Daily Target 2X Long IONQ ETF during the second quarter worth about $604,000. Finally, UBS Group AG purchased a new position in shares of Defiance Daily Target 2X Long IONQ ETF during the fourth quarter worth about $2,065,000.

Defiance Daily Target 2X Long IONQ ETF Company Profile

(Get Free Report)

The Defiance Daily Target 2X Long IONQ ETF (IONX) is an exchange-traded fund that mostly invests in information technology equity. The fund seeks to deliver 2x leveraged exposure to the daily share price movement of IonQ, Inc (IONQ), less fees and expenses, through derivatives like swap agreements IONX was launched on Mar 11, 2025 and is issued by Defiance.

See Also

Receive News & Ratings for Defiance Daily Target 2X Long IONQ ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Defiance Daily Target 2X Long IONQ ETF and related companies with MarketBeat.com's FREE daily email newsletter.